1.14 - 1.17
1.10 - 1.60
14.0K / 2.1K (Avg.)
-9.00 | -0.13
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-15.50%
Negative revenue growth while PGN.DE stands at 29.49%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-120.10%
Negative gross profit growth while PGN.DE is at 28.60%. Joel Greenblatt would examine cost competitiveness or demand decline.
-208.11%
Negative EBIT growth while PGN.DE is at 121.07%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-208.30%
Negative operating income growth while PGN.DE is at 89.88%. Joel Greenblatt would press for urgent turnaround measures.
-399.22%
Negative net income growth while PGN.DE stands at 777.48%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-400.00%
Negative EPS growth while PGN.DE is at 797.96%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-400.00%
Negative diluted EPS growth while PGN.DE is at 797.96%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
73.48%
Positive OCF growth while PGN.DE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
53.77%
Positive FCF growth while PGN.DE is negative. John Neff would see a strong competitive edge in net cash generation.
202.52%
Positive 10Y revenue/share CAGR while PGN.DE is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
202.52%
5Y revenue/share CAGR above 1.5x PGN.DE's 108.89%. David Dodd would look for consistent product or market expansions fueling outperformance.
39.40%
3Y revenue/share CAGR at 50-75% of PGN.DE's 69.49%. Martin Whitman would question if the firm lags behind competitor innovations.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
87.78%
Positive 3Y OCF/share CAGR while PGN.DE is negative. John Neff might see a big short-term edge in operational efficiency.
-342.37%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-342.37%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-251.83%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1067.01%
3Y equity/share CAGR above 1.5x PGN.DE's 505.13%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-73.67%
Firm’s AR is declining while PGN.DE shows 29.38%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-58.40%
Inventory is declining while PGN.DE stands at 5.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-18.00%
Negative asset growth while PGN.DE invests at 0.66%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-16.67%
We have a declining book value while PGN.DE shows 0.22%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-40.97%
We’re deleveraging while PGN.DE stands at 0.81%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-12.04%
We cut SG&A while PGN.DE invests at 28.97%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.